رجوع
26
مُدرج أيضًا باسم
RMSYF
OTC
نطاق اليوم
KWD 6.55
KWD 6.98
نطاق 52 أسبوعًا
KWD 4.31
KWD 7.18
حجم التداول
8
متوسط 50 يوم / 200 يوم
KWD 6.52
/
KWD 5.80
الإغلاق السابق
KWD 6.98
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 267.3 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | 0.5 | 3.9 |
| Net Margin % | 0.1 | 3.8 |
| Rev Growth 5Y % | 8.3 | 10.0 |
| D/E | 2.4 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.46
KWD 0.46 – KWD 0.48
|
20.66B | 1 |
| FY2026 |
KWD 0.40
KWD 0.40 – KWD 0.41
|
19.88B | 1 |
No quarterly estimates available
Dividend History
Yield
0.02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 8.27% annually over 5 years — modest growth
Earnings declined -97.30% over the past year
ROE of 0.48% is below average
Debt/Equity of 2.41 — high leverage
Generating 704.20M in free cash flow
P/E of 267.29 — premium valuation
النمو
Revenue Growth (5Y)
8.27%
Revenue (1Y)6.09%
Earnings (1Y)-97.30%
FCF Growth (3Y)10.32%
الجودة
Return on Equity
0.48%
ROIC3.81%
Net Margin0.14%
Op. Margin4.93%
الأمان
Debt / Equity
2.41
Current Ratio0.90
Interest Coverage2.60
التقييم
P/E Ratio
267.29
Forward P/EN/A
P/B Ratio1.28
EV/EBITDA20.39
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.09% | Revenue Growth (3Y) | 8.63% |
| Earnings Growth (1Y) | -97.30% | Earnings Growth (3Y) | -71.63% |
| Revenue Growth (5Y) | 8.27% | Earnings Growth (5Y) | -51.92% |
| Profitability | |||
| Revenue (TTM) | 17.67B | Net Income (TTM) | 24.00M |
| ROE | 0.48% | ROA | 0.11% |
| Gross Margin | 77.34% | Operating Margin | 4.93% |
| Net Margin | 0.14% | Free Cash Flow (TTM) | 704.20M |
| ROIC | 3.81% | FCF Growth (3Y) | 10.32% |
| Safety | |||
| Debt / Equity | 2.41 | Current Ratio | 0.90 |
| Interest Coverage | 2.60 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 267.29 | Forward P/E | N/A |
| P/B Ratio | 1.28 | P/S Ratio | 0.36 |
| PEG Ratio | -3.42 | Forward PEG | N/A |
| EV/EBITDA | 20.39 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 10.98% | ||
| Market Cap | 6.42B | Enterprise Value | 17.75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.67B | 16.66B | 14.98B | 13.18B | 12.86B |
| Net Income | 24.00M | 888.70M | 298.10M | 274.00M | 449.00M |
| EPS (Diluted) | 0.03 | 0.97 | 0.31 | 0.29 | 0.48 |
| Gross Profit | 13.67B | 2.01B | 1.27B | 900.60M | 832.80M |
| Operating Income | 870.50M | 833.20M | 1.64B | 230.60M | 1.59B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 22.48B | 20.89B | 21.13B | 19.58B | 19.39B |
| Total Liabilities | 16.77B | 15.37B | 16.30B | 15.06B | 14.83B |
| Shareholders' Equity | 5.02B | 4.90B | 4.15B | 3.93B | 4.03B |
| Total Debt | 12.12B | 10.94B | 11.89B | 10.70B | 10.55B |
| Cash & Equivalents | 784.40M | 662.30M | 656.10M | 314.20M | 2.96B |
| Current Assets | 4.04B | 3.87B | 3.90B | 3.29B | 5.35B |
| Current Liabilities | 4.47B | 4.18B | 3.81B | 3.75B | 3.72B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#393 of 618
النشاط الأخير
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026